Does rosuvastatin raise blood sugar
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
The Impact of Rosuvastatin on Blood Sugar Levels
Introduction to Rosuvastatin and Blood Sugar
Rosuvastatin, a widely used statin for lowering cholesterol, has been linked to changes in blood sugar levels. This article synthesizes findings from multiple studies to understand whether rosuvastatin raises blood sugar and its overall impact on glucose metabolism.
Rosuvastatin and Insulin Sensitivity
Improved Insulin Sensitivity in Normal Diet Mice
Research indicates that rosuvastatin can improve insulin sensitivity and increase glucose uptake in adipose tissue in mice on a normal diet. This suggests a potential benefit in glucose homeostasis under certain dietary conditions.
Worsening Insulin Resistance in Specific Populations
Conversely, other studies have shown that rosuvastatin can worsen insulin resistance. For instance, in hyperlipidemic patients with impaired fasting glucose, rosuvastatin treatment was associated with increased insulin resistance. Similarly, in HIV-infected adults on antiretroviral therapy, rosuvastatin significantly increased insulin resistance and fasting insulin levels.
Rosuvastatin and Blood Sugar Levels
Increase in Fasting Blood Sugar
Several studies have reported an increase in fasting blood sugar (FBS) levels with rosuvastatin use. In a comparative study with atorvastatin, rosuvastatin led to a significant rise in FBS levels in patients with type II diabetes mellitus. Additionally, in hypercholesterolemic patients, rosuvastatin dose-dependently increased insulin and glycated hemoglobin levels, indicating higher ambient glycemia.
Mixed Effects on Glucose Homeostasis
The effects of rosuvastatin on glucose homeostasis appear to be complex and dose-dependent. While it can improve insulin sensitivity in some contexts, it also impairs beta-cell function and reduces insulin secretion, leading to higher blood glucose levels in other scenarios .
Mechanisms Behind Rosuvastatin's Impact
Modulation of Insulin Signaling
Rosuvastatin may modulate insulin signaling pathways, which can influence glucose metabolism. Studies in insulin-resistant mice have shown that rosuvastatin can partially reverse decreases in insulin receptor substrate 2 and protein kinase B pathways, improving insulin resistance independently of its cholesterol-lowering effects .
Reduction in Adiponectin Levels
Rosuvastatin has been found to reduce adiponectin levels, a hormone that enhances insulin sensitivity. This reduction is associated with decreased insulin sensitivity and increased blood sugar levels in hypercholesterolemic patients.
Conclusion
In summary, while rosuvastatin can improve insulin sensitivity and glucose uptake in certain conditions, it also has the potential to increase fasting blood sugar levels and worsen insulin resistance, particularly in specific populations such as those with impaired fasting glucose or HIV. The dual effects of rosuvastatin on glucose homeostasis highlight the need for careful consideration of its use, especially in patients at risk of diabetes.
Sources and full results
Most relevant research papers on this topic